KMT2A and acute leukemia: KMT2A‐rearrangements occur in about 10% of acute leukemia patients and are associated with a particularly poor prognosis, while NPM1mut are present in about 30% of patients with acute myeloid leukemia and are linked to relatively favorable outcomes after chemotherapy.51